• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company's U.S. Subsidiary

    12/6/22 8:00:00 AM ET
    $ARAY
    $EDAP
    $HPQ
    $INTC
    Medical/Dental Instruments
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $ARAY alert in real time by email

    LYON, France, December 6, 2022 -- EDAP TMS SA (NASDAQ:EDAP) (the "Company"), the global leader in robotic energy-based therapies, announced today that the Company has hired medical capital equipment finance industry veteran Ken Mobeck as Chief Financial Officer of EDAP Technomed Inc., the Company's U.S. subsidiary. During his extensive career, Mr. Mobeck has demonstrated significant leadership expertise in driving transformational business growth while establishing a track record of creating lasting shareholder value.

    Marc Oczachowski, Chairman and Chief Executive Officer of EDAP TMS, stated, "I am very pleased to welcome Ken onboard our U.S. subsidiary. Ken is a great addition to Ryan Rhodes's leadership team and will be key to supporting the ongoing expansion of our U.S. organization and driving the continued strong growth of our business in the U.S."

    Ryan Rhodes, Chief Executive Officer of EDAP Technomed Inc., stated, "Ken is the ideal candidate to be our subsidiary's first CFO as we begin to significantly ramp up the business with the growth of our flagship Focal One® Robotic HIFU platform. He brings over 25 years of financial leadership across all finance disciplines with extensive experience building strong relationships to drive operating results. His knowledge of capital equipment along with his medical device and investor relations experience at leading organizations, including Accuray, will be invaluable as we move forward."

    "EDAP Technomed Inc. is at a critical juncture in the organization's growth. I'm looking forward to working with Ryan and the extended team to accelerate growth in our U.S. business and provide more patients with access to our precise, innovative Focal One robotic technology," said Mr. Mobeck.

    Prior to joining EDAP Technomed, Ken served as Vice President of Finance and Investor Relations at medical device manufacturer Accuray Incorporated (NASDAQ:ARAY), one of the leading radiation therapy companies in the industry. During his tenure with the organization, he was responsible for driving key initiatives to improve the company's operating performance. Prior to joining Accuray, Ken served as Vice President of Finance at optical networking leader Lumentum (NASDAQ:LITE) where he helped raise $900 million in debt financing to grow the business from $900 million to more than $1.6 billion in only three years. Before Lumentum, he spent over two decades in positions with increasing levels of responsibility at some of Silicon Valley's most innovative companies including Silicon Graphics, Hewlett Packard (NYSE:HPQ), KLA (NASDAQ:KLAC) and Intel Corporation (NASDAQ:INTC), where he was involved in high scale growth, business transformation and mergers and acquisitions. Notably, while employed at KLA, he helped grow revenue from $1.3 billion to $2.7 billion over seven years.

    About EDAP TMS SA

    A recognized leader in the global therapeutic ultrasound market. EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One® in Europe and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith® i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit http://www.edap-tms.com, us.hifu-prostate.com and www.focalone.com.

    Forward-Looking Statements

    In addition to historical information, this press release contains forward-looking statements. Such statements are based on management's current expectations and are subject to a number of risks and uncertainties, including matters not yet known to us or not currently considered material by us, and there can be no assurance that anticipated events will occur or that the objectives set out will actually be achieved. Important factors that could cause actual results to differ materially from the results anticipated in the forward-looking statements include, among others, the clinical status and market acceptance of our HIFU devices and the continued market potential for our lithotripsy device, as well as the length and severity of the recent COVID-19 outbreak, including its impacts across our businesses on demand for our devices and services. Factors that may cause such a difference also may include, but are not limited to, those described in the Company's filings with the Securities and Exchange Commission and in particular, in the sections "Cautionary Statement on Forward-Looking Information" and "Risk Factors" in the Company's Annual Report on Form 20-F.

    Company Contact

    Blandine Confort

    Investor Relations / Legal Affairs

    EDAP TMS SA

    +33 4 72 15 31 50

    [email protected]

    Investor Contact

    John Fraunces

    LifeSci Advisors, LLC

    212-915-2568

    [email protected]

     



    Primary Logo

    Get the next $ARAY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ARAY
    $EDAP
    $HPQ
    $INTC

    CompanyDatePrice TargetRatingAnalyst
    KLA Corporation
    $KLAC
    5/1/2025$770.00 → $800.00Hold
    TD Cowen
    Intel Corporation
    $INTC
    4/30/2025$18.00Sell
    Seaport Research Partners
    Intel Corporation
    $INTC
    4/25/2025$23.00 → $22.00Neutral
    Mizuho
    Intel Corporation
    $INTC
    4/25/2025$22.00 → $21.00Neutral
    UBS
    Intel Corporation
    $INTC
    4/25/2025$25.00 → $22.00Equal Weight
    Wells Fargo
    Intel Corporation
    $INTC
    4/25/2025$18.00 → $14.00Sell
    Rosenblatt
    Intel Corporation
    $INTC
    4/25/2025$25.00 → $23.00Equal-Weight
    Morgan Stanley
    Intel Corporation
    $INTC
    4/25/2025$23.00 → $20.00Underweight
    Analyst
    More analyst ratings

    $ARAY
    $EDAP
    $HPQ
    $INTC
    Leadership Updates

    Live Leadership Updates

    See more
    • ISS and Glass Lewis Join ADL and JLens in Recommending AGAINST Anti-Israel Shareholder Proposals at Intel, General Dynamics and Lockheed Martin

      Reiterates Call for Shareholders to Reject Proposals Motivated by Antisemitic Boycott, Divestment and Sanctions (BDS) Movement ADL (Anti-Defamation League) and its affiliate, Jlens, welcome the decisions of the two leading independent proxy advisory firms, Institutional Shareholder Services ("ISS") and Glass, Lewis & Co. ("Glass Lewis"), to recommend that investors vote AGAINST anti-Israel shareholder proposals at the upcoming annual meetings of Intel Corporation (NASDAQ:INTC), General Dynamics (NYSE:GD) and Lockheed Martin Corporation (NYSE:LMT). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505942003/en/ ADL and its Regist

      5/5/25 8:00:00 AM ET
      $GD
      $INTC
      $LMT
      Marine Transportation
      Industrials
      Semiconductors
      Technology
    • Intel Appoints Lip-Bu Tan as Chief Executive Officer

      Tan to join Intel board of directors Intel Corporation (NASDAQ:INTC) today announced that its board of directors has appointed Lip-Bu Tan, an accomplished technology leader with deep semiconductor industry experience, as chief executive officer, effective March 18. He succeeds Interim Co-CEOs David Zinsner and Michelle (MJ) Johnston Holthaus. Tan will also rejoin the Intel board of directors after stepping down from the board in August 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250312399008/en/Lip-Bu Tan was appointed chief executive officer of Intel Corporation in March 2025. He also serves on the company's board of d

      3/12/25 4:15:00 PM ET
      $INTC
      Semiconductors
      Technology
    • HP Inc. Names Gianluca Pettiti to Board of Directors

      PALO ALTO, Calif., Feb. 21, 2025 (GLOBE NEWSWIRE) -- HP Inc. (NYSE:HPQ) today announced the appointment of Gianluca Pettiti to its Board of Directors. Mr. Pettiti is Executive Vice President and President, Life Sciences, Diagnostics and Applied for Thermo Fisher Scientific Inc., a global life sciences company. His appointment is effective immediately. "We're excited to welcome Gianluca to the HP Board of Directors," said Chip Bergh, Chair of the HP Board. "He brings invaluable global expertise and a proven track record of fostering innovation at the intersection of technology and life sciences. His experience spearheading digital and AI initiatives will be instrumental in advancing our bu

      2/21/25 4:05:00 PM ET
      $HPQ
      Computer Manufacturing
      Technology

    $ARAY
    $EDAP
    $HPQ
    $INTC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $ARAY
    $EDAP
    $HPQ
    $INTC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Director Yeary Frank D converted options into 35,146 shares, increasing direct ownership by 4,339% to 35,956 units (SEC Form 4)

      4 - INTEL CORP (0000050863) (Issuer)

      5/8/25 5:25:47 PM ET
      $INTC
      Semiconductors
      Technology
    • Director Weisler Dion J converted options into 11,364 shares and covered exercise/tax liability with 3,410 shares, increasing direct ownership by 18% to 53,289 units (SEC Form 4)

      4 - INTEL CORP (0000050863) (Issuer)

      5/8/25 5:23:22 PM ET
      $INTC
      Semiconductors
      Technology
    • Director Smith Stacy J converted options into 10,068 shares, increasing direct ownership by 1,006% to 11,069 units (SEC Form 4)

      4 - INTEL CORP (0000050863) (Issuer)

      5/8/25 5:22:20 PM ET
      $INTC
      Semiconductors
      Technology
    • KLA Declares Regular Cash Dividend

      MILPITAS, Calif., May 8, 2025 /PRNewswire/ -- The KLA Corporation (NASDAQ:KLAC) Board of Directors today declared a quarterly cash dividend of $1.90 per share on its common stock, payable on June 3, 2025 to KLA shareholders of record as of the close of business on May 19, 2025. Logo: https://mma.prnewswire.com/media/806571/KLA_Corporation_Logo.jpg About KLA: KLA Corporation ("KLA") develops industry-leading equipment and services that enable innovation throughout the electronics industry. We provide advanced process control and process-enabling solutions for manufacturing wafers and reticles, integrated circuits, packaging and printed circuit boards. In close collaboration with leading cust

      5/8/25 4:15:00 PM ET
      $KLAC
      Electronic Components
      Technology
    • Accuray Showcases New Long-Term Data¹ on Benefits of 5 Session Radiotherapy Treatment for Men with Prostate Cancer at ESTRO 2025

      More than 40 Clinical Studies Using Accuray Technology Presented at ESTRO 2025; Company Highlights Innovation and Educational Symposia MADISON, Wis., May 7, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) announced today that new data presented at the European Society for Radiotherapy and Oncology (ESTRO) meeting reinforces the benefits of the company's CyberKnife® System in the treatment of prostate cancer at multiple stages of the cancer journey. The studies, shared at the annual congress held in Vienna, Austria, indicate the system's accuracy and precision enable treatment of high-risk disease, as well as recurrent prostate cancer following prostatectomy, with stereotactic body r

      5/7/25 7:35:00 AM ET
      $ARAY
      Medical/Dental Instruments
      Health Care
    • HP Inc. to Announce Second Quarter Fiscal 2025 Earnings on May 28, 2025

      PALO ALTO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- HP Inc. (NYSE:HPQ) will present a live audio webcast of a conference call to review financial results for the second fiscal quarter ended April 30, 2025 on Wednesday, May 28, 2025 at 5:00 p.m. ET / 2:00 p.m. PT. The webcast will be available at www.hp.com/investor/2025Q2Webcast. A replay of the audio webcast will be available at the same website shortly after the call and will remain available for approximately one year. About HP Inc. HP Inc. (NYSE:HPQ) is a global technology leader and creator of solutions that enable people to bring their ideas to life and connect to the things that matter most. Operating in more than 170 c

      5/6/25 4:15:53 PM ET
      $HPQ
      Computer Manufacturing
      Technology

    $ARAY
    $EDAP
    $HPQ
    $INTC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO Gelsinger Patrick P bought $251,198 worth of shares (11,150 units at $22.53), increasing direct ownership by 12% to 105,033 units (SEC Form 4)

      4 - INTEL CORP (0000050863) (Issuer)

      11/6/24 4:06:28 PM ET
      $INTC
      Semiconductors
      Technology
    • CEO Gelsinger Patrick P bought $251,946 worth of shares (12,500 units at $20.16) (SEC Form 4)

      4 - INTEL CORP (0000050863) (Issuer)

      8/7/24 4:23:22 PM ET
      $INTC
      Semiconductors
      Technology
    • Whitters Joseph E bought $156,045 worth of shares (100,000 units at $1.56), increasing direct ownership by 22% to 561,053 units (SEC Form 4)

      4 - ACCURAY INC (0001138723) (Issuer)

      5/30/24 4:10:11 PM ET
      $ARAY
      Medical/Dental Instruments
      Health Care

    $ARAY
    $EDAP
    $HPQ
    $INTC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • TD Cowen reiterated coverage on KLA Corporation with a new price target

      TD Cowen reiterated coverage of KLA Corporation with a rating of Hold and set a new price target of $800.00 from $770.00 previously

      5/1/25 6:40:04 AM ET
      $KLAC
      Electronic Components
      Technology
    • Seaport Research Partners initiated coverage on Intel with a new price target

      Seaport Research Partners initiated coverage of Intel with a rating of Sell and set a new price target of $18.00

      4/30/25 10:40:07 AM ET
      $INTC
      Semiconductors
      Technology
    • Mizuho reiterated coverage on Intel with a new price target

      Mizuho reiterated coverage of Intel with a rating of Neutral and set a new price target of $22.00 from $23.00 previously

      4/25/25 9:06:06 AM ET
      $INTC
      Semiconductors
      Technology

    $ARAY
    $EDAP
    $HPQ
    $INTC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Lumentum Holdings Inc.

      SC 13G/A - Lumentum Holdings Inc. (0001633978) (Subject)

      11/14/24 7:53:37 PM ET
      $LITE
      Telecommunications Equipment
      Telecommunications
    • Amendment: SEC Form SC 13G/A filed by EDAP TMS S.A.

      SC 13G/A - EDAP TMS SA (0001041934) (Subject)

      11/14/24 3:36:33 PM ET
      $EDAP
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Amendment: SEC Form SC 13G/A filed by HP Inc.

      SC 13G/A - HP INC (0000047217) (Subject)

      11/12/24 3:53:24 PM ET
      $HPQ
      Computer Manufacturing
      Technology

    $ARAY
    $EDAP
    $HPQ
    $INTC
    Financials

    Live finance-specific insights

    See more
    • KLA Declares Regular Cash Dividend

      MILPITAS, Calif., May 8, 2025 /PRNewswire/ -- The KLA Corporation (NASDAQ:KLAC) Board of Directors today declared a quarterly cash dividend of $1.90 per share on its common stock, payable on June 3, 2025 to KLA shareholders of record as of the close of business on May 19, 2025. Logo: https://mma.prnewswire.com/media/806571/KLA_Corporation_Logo.jpg About KLA: KLA Corporation ("KLA") develops industry-leading equipment and services that enable innovation throughout the electronics industry. We provide advanced process control and process-enabling solutions for manufacturing wafers and reticles, integrated circuits, packaging and printed circuit boards. In close collaboration with leading cust

      5/8/25 4:15:00 PM ET
      $KLAC
      Electronic Components
      Technology
    • HP Inc. to Announce Second Quarter Fiscal 2025 Earnings on May 28, 2025

      PALO ALTO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- HP Inc. (NYSE:HPQ) will present a live audio webcast of a conference call to review financial results for the second fiscal quarter ended April 30, 2025 on Wednesday, May 28, 2025 at 5:00 p.m. ET / 2:00 p.m. PT. The webcast will be available at www.hp.com/investor/2025Q2Webcast. A replay of the audio webcast will be available at the same website shortly after the call and will remain available for approximately one year. About HP Inc. HP Inc. (NYSE:HPQ) is a global technology leader and creator of solutions that enable people to bring their ideas to life and connect to the things that matter most. Operating in more than 170 c

      5/6/25 4:15:53 PM ET
      $HPQ
      Computer Manufacturing
      Technology
    • Lumentum Announces Fiscal Third Quarter 2025 Financial Results

      Net revenue of $425.2 million GAAP gross margin of 28.8%; Non-GAAP gross margin of 35.2% GAAP operating loss of 8.9%; Non-GAAP operating margin of 10.8% GAAP diluted net loss per share of $0.64; Non-GAAP diluted net income per share of $0.57 Lumentum Holdings Inc. ("Lumentum" or the "Company") today reported results for its fiscal third quarter ended March 29, 2025. "In my first 90 days as CEO, it's become clear that Lumentum is uniquely positioned to lead as the convergence of optics and electronics accelerates AI data center scaling. Our innovations—from advanced EMLs to ultra-high-power lasers—are driving transformative power efficiencies across cloud, AI, and long-haul network

      5/6/25 4:03:00 PM ET
      $LITE
      Telecommunications Equipment
      Telecommunications

    $ARAY
    $EDAP
    $HPQ
    $INTC
    SEC Filings

    See more
    • SEC Form 8-K filed by KLA Corporation

      8-K - KLA CORP (0000319201) (Filer)

      5/8/25 4:24:42 PM ET
      $KLAC
      Electronic Components
      Technology
    • Lumentum Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Lumentum Holdings Inc. (0001633978) (Filer)

      5/6/25 4:26:14 PM ET
      $LITE
      Telecommunications Equipment
      Telecommunications
    • SEC Form 144 filed by KLA Corporation

      144 - KLA CORP (0000319201) (Subject)

      5/6/25 10:16:19 AM ET
      $KLAC
      Electronic Components
      Technology